GHW International (HKG:9933)

Market Cap	1.60B -23.2%
Revenue (ttm)	4.30B +11.2%
Net Income	16.81M +143.9%
EPS	0.02 +134.3%
Shares Out	945.22M
PE Ratio	99.35
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	88,000
Average Volume	171,250
Open	1.670
Previous Close	1.630
Day's Range	1.620 - 1.710
52-Week Range	1.160 - 2.640
Beta	0.59
RSI	50.72
Earnings Date	Mar 24, 2026

About GHW International

GHW International, an investment holding company, manufactures and sells chemical and pharmaceutical products in the People’s Republic of China, Europe, Vietnam, rest of Asia, and internationally. It operates through seven segments: Methylamine Industry Series, Applied Chemicals Series, Advanced Materials Intermediates Series, Green Products, Pharmaceutical intermediates and Active Pharmaceutical ingredients (“APIs”), Iodine Derivatives and Supporting products, and Happy Elephant Planet, Advanced Medical and Health Products segments. The Methyl...

• Industry: Chemicals
• Sector: Materials
• Founded: 1995
• Employees: 1,093
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 9933

Financial Performance

In 2024, GHW International's revenue was 3.86 billion, an increase of 20.02% compared to the previous year's 3.22 billion. Earnings were 12.75 million, an increase of 368.17%.

Financial numbers in CNY